The University of Texas MD Anderson Cancer Center
Academic institution

Houston, Texas
USA


The University of Texas MD Anderson Cancer Center, together with Gustave Roussy, initiated the WIN Consortium
The University of Texas MD Anderson Cancer Center is one of the world’s most respected centers devoted exclusively to cancer patient care, research, education and prevention. MD Anderson has treated more than one million cancer patients since it opened in 1944. At MD Anderson, important scientific knowledge gained in the laboratory is rapidly translated to clinical care. In FY14, MD Anderson invested more than $735 million in research, an increase of 35% in the past five years.

MD Anderson's Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy is an international center of clinical excellence focusing on using the latest advances in genetic information to develop safe, more effective treatments for patients on a case-by-case basis.

Represented by:

John Mendelsohn logotype
John Mendelsohn

Director, Khalifa Institute for Personalized Cancer Medicine and Past-President, the University of Texas MD Anderson Cancer Center (USA)

Hilario Mata logotype
Hilario Mata

Director of Global Academic Programs, The University of Texas, MD Anderson Cancer Center (USA)

George Wilding logotype
George Wilding

Vice Provost, Clinical and Interdisciplinary Research, The University of Texas, MD Anderson Cancer Center (USA)

Oliver Bogler logotype
Oliver Bogler

Senior Vice President for Academic Affairs, VP, Global Academic Programs & Professor, Neurosurgery-Research, The University of Texas, MD Anderson Cancer Center (USA)